What do cardiologists know about the effects of cardiovascular agents on sexual function? A survey among Dutch cardiologists. Part I

by Nicolai, M. P. J., Liem, S. S., Both, S., Pelger, R. C. M., Putter, H., Schalij, M. J., Elzevier, H. W.
Published 2013

A review of the positive and negative effects of cardiovascular drugs on sexual function: a proposed table for use in clinical practice

by Nicolai, M. P. J., Liem, S. S., Both, S., Pelger, R. C. M., Putter, H., Schalij, M. J., Elzevier, H. W.
Published 2013

The MiniArc sling for female stress urinary incontinence: clinical results after 1-year follow-up

by Hogewoning, C. R. C., Ruhe, I. M. C., Bekker, M. D., Hogewoning, C. J. A., Putter, H., DeRuiter, M. C., Pelger, R. C. M., Elzevier, H. W.
Published 2011

Epigenetic status of LINE-1 predicts clinical outcome in early-stage rectal cancer

by Benard, A, van de Velde, C J H, Lessard, L, Putter, H, Takeshima, L, Kuppen, P J K, Hoon, D S B
Published 2013

Quality of life in relation to tamoxifen or exemestane treatment in postmenopausal breast cancer patients: a Tamoxifen Exemestane Adjuvant Multinational (TEAM) Trial side study

by van Nes, J. G. H., Fontein, D. B. Y., Hille, E. T. M., Voskuil, D. W., van Leeuwen, F. E., de Haes, J. C. J. M., Putter, H., Seynaeve, C., Nortier, J. W. R., van de Velde, C. J. H.
Published 2012

Clinical prognostic value of combined analysis of Aldh1, Survivin, and EpCAM expression in colorectal cancer

by Goossens-Beumer, I J, Zeestraten, E C M, Benard, A, Christen, T, Reimers, M S, Keijzer, R, Sier, C F M, Liefers, G J, Morreau, H, Putter, H, Vahrmeijer, A L, van de Velde, C J H, Kuppen, P J K
Published 2014

Validity of the online PREDICT tool in older patients with breast cancer: a population-based study

by de Glas, N A, Bastiaannet, E, Engels, C C, de Craen, A J M, Putter, H, van de Velde, C J H, Hurria, A, Liefers, G J, Portielje, J E A
Published 2016

CYP2D6 genotype- and endoxifen-guided tamoxifen dose escalation increases endoxifen serum concentrations without increasing side effects

by Dezentjé, V. O., Opdam, F. L., Gelderblom, H., Hartigh den, J., Van der Straaten, T., Vree, R., Maartense, E., Smorenburg, C. H., Putter, H., Dieudonné, A. S., Neven, P., Van de Velde, C. J. H., Nortier, J. W. R., Guchelaar, H.-J.
Published 2015

No increase in Kidney Injury Molecule-1 and Neutrophil Gelatinase-Associated Lipocalin excretion following intravenous contrast enhanced-CT

by Kooiman, Judith, van de Peppel, Wilke R., Sijpkens, Yvo W. J., Brulez, Harald F. H., de Vries, P. M., Nicolaie, Mioara A., Putter, H., Huisman, Menno V., van der Kooij, W., van Kooten, Cees, Rabelink, Ton J.
Published 2015

Effects of neoadjuvant chemotherapy with or without zoledronic acid on pathological response: A meta-analysis of randomised trials

by Kroep, J.R., Charehbili, A., Coleman, R.E., Aft, R.L., Hasegawa, Y., Winter, M.C., Weilbaecher, K., Akazawa, K., Hinsley, S., Putter, H., Liefers, G.J., Nortier, J.W.R., Kohno, N.
Published 2015

Do type 1 receptor tyrosine kinases inform treatment choice? A prospectively planned analysis of the TEAM trial

by Bartlett, J M S, Brookes, C L, Piper, T, van de Velde, C J H, Stocken, D, Lyttle, N, Hasenburg, A, Quintayo, M A, Kieback, D G, Putter, H, Markopoulos, C, Kranenbarg, E M-K, Mallon, E A, Dirix, L Y, Seynaeve, C, Rea, D W
Published 2013

Netherlands Public Private Partnerships Aimed at Co-Innovation in the Potato Value Chain in Emerging Markets

by Kempenaar C., Blom-Zandstra M., Brouwer T.A., De Putter H., De Vries S., Hengsdijk H., Janssens S. R. M., Kessel G.J.T., Van Koesveld J.M., Meijer B.J.M., Pronk A.A., Schoutsen M., Ter Beke F., Van den Brink L., Michielsen J.M., Schepers H.T.A.M., Wustman R., Zhang X., Qiu Y.T., Haverkort A.J.
Published 2017-11-01

The prognostic and predictive value of Tregs and tumor immune subtypes in postmenopausal, hormone receptor-positive breast cancer patients treated with adjuvant endocrine therapy:...

by Engels, C. C., Charehbili, A., van de Velde, C. J. H., Bastiaannet, E., Sajet, A., Putter, H., van Vliet, E. A., van Vlierberghe, R. L. P., Smit, V. T. H. B. M., Bartlett, J. M. S., Seynaeve, C., Liefers, G. J., Kuppen, P. J. K.
Published 2015

Thyroid function alters during neoadjuvant chemotherapy in breast cancer patients: results from the NEOZOTAC trial (BOOG 2010-01)

by de Groot, S., Janssen, L. G. M., Charehbili, A., Dijkgraaf, E. M., Smit, V. T. H. B. M., Kessels, L. W., van Bochove, A., van Laarhoven, H. W. M., Meershoek-Klein Kranenbarg, E., van Leeuwen-Stok, A. E., van de Velde, C. J. H., Putter, H., Nortier, J. W. R., van der Hoeven, J. J. M., Pijl, H., Kroep, J. R.
Published 2015